New Orleans, LA11 Active Studies

Atopic Dermatitis Clinical Trials in New Orleans, LA

Find 11 actively recruiting atopic dermatitis clinical trials in New Orleans, LA. Connect with local research sites and explore new treatment options.

11
Active Trials
11
Sponsors
2,629
Enrolling

Recruiting Atopic Dermatitis Studies in New Orleans

NCT05768139Recruiting

First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Study STX-478-101 is a multipart, open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of STX-478 (LY4064809) in participants with...

New Orleans, LAPHASE1880 participantsEli Lilly and Company
View Study Details
NCT06792552Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors...

New Orleans, LAPHASE1414 participantsNextCure, Inc.
View Study Details
NCT05889624Recruiting

Responding With Evidence and Access for Childhood Headaches

This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world car...

New Orleans, LANA400 participantsChildren's Hospital Medical Center, Cincinnati
View Study Details
NCT05200923Recruiting

Pelvic Health Electrically Evoked Recording (PEER) 2 Study

To collect physiological signals at several timepoints during the therapy evaluation period....

New Orleans, LANA300 participantsMedtronicNeuro
View Study Details
NCT06656390Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

This is a first-in-human (FIH), open-label, multicenter dose escalation and expansion study of ALK201. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and ant...

New Orleans, LAPHASE1202 participantsShanghai Allink Biotherapeutics Co., Ltd.
View Study Details
NCT05270213Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

RBS2418 (investigational product) is a specific immune modulator, working through ectonucleotide pyrophosphatase/phosphodiesterase I (ENPP1), designed to lead to anti-tumor immunity by increasing endo...

New Orleans, LAPHASE1164 participantsRiboscience, LLC.
View Study Details
NCT05277168Recruiting

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

The study (dose escalation/expansion) is being conducted to assess the safety and tolerability of SHR-A1904 in subjects with advanced solid tumors, and to determine maximum tolerated dose (MTD) and/or...

New Orleans, LAPHASE183 participantsJiangsu HengRui Medicine Co., Ltd.
View Study Details
NCT06730347Recruiting

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Study CP-MGD019-03 is an open-label study of lorigerlimab in participants with platinum-resistant ovarian cancer (PROC) or clear cell gynecologic cancer (CCGC). Approximately 60 participants will be e...

New Orleans, LAPHASE280 participantsMacroGenics
View Study Details
NCT05491525Recruiting

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

The purpose of this study is to evaluate the safety, efficacy, and PK of vibegron in pediatric participants with NDO who are regularly using CIC...

New Orleans, LAPHASE271 participantsUrovant Sciences GmbH
View Study Details
NCT06008626Recruiting

Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

This is a prospective, multicenter, non-randomized single-arm safety and performance study to collect data to evaluate the safety of the Cryosa procedure to treat obstructive sleep apnea (OSA) in pati...

New Orleans, LANA25 participantsCryosa, Inc.
View Study Details
NCT07077902Recruiting

A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa

This is a phase 2a, open label study. As psoriasis and Hidradenitis Suppurativa (HS) share multiple inflammatory pathways, the investigators hypothesize that the use of topical roflumilast 0.3% foam ...

New Orleans, LAPHASE210 participantsTulane University
View Study Details

About Atopic Dermatitis Clinical Trials in New Orleans

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 11 atopic dermatitis clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 2,629 participants. Research is being sponsored by Eli Lilly and Company, NextCure, Inc., Children's Hospital Medical Center, Cincinnati and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in New Orleans — FAQ

Are there atopic dermatitis clinical trials in New Orleans?

Yes, there are 11 atopic dermatitis clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Orleans?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.

Are clinical trials in New Orleans free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 11 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated July 21, 2026 from ClinicalTrials.gov